Michigan Medicine Non-Alcoholic Fatty Liver Disease Clinic

The Michigan Medicine Non-Alcoholic Fatty Liver Disease (NAFLD) Clinic is focused on the care of patients with NAFLD and non-alcoholic steatohepatitis (NASH), including those with cirrhosis from NAFLD and NASH. This multidisciplinary clinic consists of liver disease physicians, advanced practitioners, and GI nutritionists who specialize in the care of this unique patient population. The Michigan Medicine NAFLD Clinic provides comprehensive diagnostic evaluation, assessment of disease severity, and individualized treatment plans. In addition, we are committed to advancing knowledge and improving patient care through research. Patients in this clinic have the opportunity to participate in cutting-edge research studies, including new pharmacologic therapies. The clinic is located in the Taubman Center at University Hospital in Ann Arbor.

To Learn More and Make an Appointment, please click here.  


Monica Konerman, MD, MSc
Founder and Director of the Michigan Medicine NAFLD Clinic. Dr Konerman cares for patients with all forms of liver disease, including the evaluation and treatment of patients in need of a liver transplant. She specializes in the diagnosis and treatment of patients with NAFLD.

Hari Conjeevaram, MD, MS
Co-Director of the Michigan Medicine NAFLD Clinic and Director of the GI Fellowship Program at Michigan Medicine.

Lisa Glass, MD

Hellan Kwon, MD

Nurse Practitioner

Andrea Gajos, MSN, ANP-BC

Clinical Studies

The exact reason why some patients develop NAFLD while others with similar risk factors do not is unknown. Similarly, there is not an accurate way to predict why some patients develop advanced disease. Research is critical to add to our understanding of NAFLD and to the improvement of the treatment of patients. There are multiple studies ongoing at Michigan Medicine related to NAFLD and NASH. To find actively recruiting research studies, please visit the NAFLD page under Clinical Studies.